신경퇴행 질환에서 확장된 혈관주위공간의 임상 의의|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background: Enlarged perivascular space (ePVS) is recently reported to be associated with cerebral small vessel disease (SVD) and Alzheimer’s disease (AD). The topographical location of ePVS may relate to the underlying pathology; basal ganglia (BG)-ePVS has been associated with cerebral vascular diseases and centrum semi-ovale (CSO)-ePVS associated with cerebral amyloid angiopathy (CAA). However, the effects of ePVS on various neurological conditions remain still controversial. To investigate the clinical relevance of ePVS in neurodegenerative diseases, we tested relationships between ePVS and cognition, markers of SVD, vascular risk factors, or amyloid pathology.
Methods: We retrospectively reviewed 292 patients (133 AD dementia, 106 mild cognitive impairment, 39 other neurodegenerative diseases, 14 subjective cognitive decline) who underwent both amyloid positron emission tomography and brain magnetic resonance imaging. Vascular risk factors and cognitive tests results were collected. The ePVS in the BG and CSO, SVD markers and the volume of white matter hyperintensities were measured.
Results: There were no significant differences in the severity and distribution of ePVS among clinical syndromes. Both BG- and CSO-ePVS were not related to cognitive function. Patients with lacunes were more likely to have high-degree BG-ePVS. High degree CSO-ePVS had an odds ratio (OR) for amyloid positive of 2.351, while BG-ePVS was a negative predictor for amyloid pathology (OR, 0.336).
Conclusions: Our findings support that ePVS has different underlying pathologies according to the cerebral topography. BG-ePVS would be attributed to hypertensive angiopathy considering the relation with SVD markers, whereas and CSO-ePVS would be attributed to CAA considering the association with amyloid pathology.

번역하기

참고문헌 (Reference)

1 임영희 ; 문원진, "늘어난 혈관주위공간: 노화와 신경계질환에서의 임상적의의와 영상의 역할" 대한영상의학회 83 (83): 538-558, 2022

2 Collij LE, "Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent" 48 : 2169-2182, 2021

3 Ramirez J, "Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer’s disease patients and normal elderly from the Sunnybrook dementia study" 43 : 415-424, 2015

4 Martinez-Ramirez S, "Topography of dilated perivascular spaces in subjects from a memory clinic cohort" 80 : 1551-1556, 2013

5 Shams S, "Topography and determinants of magnetic resonance imaging(MRI)-visible perivascular spaces in a large memory clinic cohort" 6 : e006279-, 2017

6 Wenning GK, "The movement disorder society criteria for the diagnosis of multiple system atrophy" 37 : 1131-1148, 2022

7 Jessen NA, "The glymphatic system : a beginner’s guide" 40 : 2583-2599, 2015

8 Rasmussen MK, "The glymphatic pathway in neurological disorders" 17 : 1016-1024, 2018

9 Maggi P, "The formation of inflammatory demyelinated lesions in cerebral white matter" 76 : 594-608, 2014

10 Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease" 7 : 270-279, 2011